Prelude Capital Management LLC Increases Stake in Harrow Health, Inc. (NASDAQ:HROW)

Prelude Capital Management LLC boosted its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 6.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,456 shares of the company’s stock after purchasing an additional 2,753 shares during the quarter. Prelude Capital Management LLC […]

Related Keywords

United States ,American ,Markl Baum , ,Eton Pharmaceuticals Inc ,Pharmaceuticals Inc ,Securities Exchange Commission ,York Mellon Corp ,Harrow Health Company Profile ,Surface Ophthalmics Inc ,Da Davidson ,American International Group Inc ,Royce Associates ,Quarter For Harrow Health ,Harrow Health ,News Ratings For Harrow Health Daily ,Nasdaq ,Prelude Capital Management ,Opaleye Management Inc ,Harrow Health Stock Performance ,Harrow Health Inc ,Silver Oak Securities Incorporated ,Free Report ,Capital Management ,Oak Securities Incorporated ,New York Mellon Corp ,American International Group ,Exchange Commission ,Opaleye Management ,Get Free Report ,Surface Ophthalmics ,Melt Pharmaceuticals ,Eton Pharmaceuticals ,Visit Holdingschannel ,Harrow Health Daily ,Nasdaq Hrow ,Throw ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,